CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ROE
Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for the quarter ending 2026-06-27 was -8.32%, a change of -6.39% year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for the quarter ending 2026-03-28 was -6.22%, a change of -5.49% year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for the quarter ending 2025-12-27 was -4.49%, a 714.84% decline year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for the quarter ending 2025-09-27 was -2.34%, a 120.66% decline year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for fiscal 2025 was -4.48%, a 714.78% decline from fiscal 2024.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for fiscal 2024 was 0.73%, a 94.53% decline from fiscal 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for fiscal 2023 was 13.34%, a 19.30% decline from fiscal 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roe for fiscal 2022 was 16.52%, a 5.19% increase from fiscal 2021.